These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36217943)

  • 1. Plasma proteomics identify potential severity biomarkers from COVID-19 associated network.
    Sahin AT; Yurtseven A; Dadmand S; Ozcan G; Akarlar BA; Kucuk NEO; Senturk A; Ergonul O; Can F; Tuncbag N; Ozlu N
    Proteomics Clin Appl; 2023 Mar; 17(2):e2200070. PubMed ID: 36217943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.
    Messina F; Giombini E; Montaldo C; Sharma AA; Zoccoli A; Sekaly RP; Locatelli F; Zumla A; Maeurer M; Capobianchi MR; Lauria FN; Ippolito G
    Cell Death Dis; 2021 Aug; 12(8):788. PubMed ID: 34385425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.
    Haas P; Muralidharan M; Krogan NJ; Kaake RM; Hüttenhain R
    J Proteome Res; 2021 Feb; 20(2):1133-1152. PubMed ID: 33464917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
    Stukalov A; Girault V; Grass V; Karayel O; Bergant V; Urban C; Haas DA; Huang Y; Oubraham L; Wang A; Hamad MS; Piras A; Hansen FM; Tanzer MC; Paron I; Zinzula L; Engleitner T; Reinecke M; Lavacca TM; Ehmann R; Wölfel R; Jores J; Kuster B; Protzer U; Rad R; Ziebuhr J; Thiel V; Scaturro P; Mann M; Pichlmair A
    Nature; 2021 Jun; 594(7862):246-252. PubMed ID: 33845483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19.
    Zoodsma M; de Nooijer AH; Grondman I; Gupta MK; Bonifacius A; Koeken VACM; Kooistra E; Kilic G; Bulut O; Gödecke N; Janssen N; Kox M; Domínguez-Andrés J; van Gammeren AJ; Ermens AAM; van der Ven AJAM; Pickkers P; Blasczyk R; Behrens GMN; van de Veerdonk FL; Joosten LAB; Xu CJ; Eiz-Vesper B; Netea MG; Li Y
    Front Immunol; 2022; 13():1027122. PubMed ID: 36405747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
    Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
    J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients.
    Alaiya A; Alshukairi A; Shinwari Z; Al-Fares M; Alotaibi J; AlOmaim W; Alsharif I; Bakheet R; Alharbi L; Allam R; Asiri A; Memish Z; Alromaih K; Al-Mozaini M
    J Inflamm Res; 2021; 14():4313-4328. PubMed ID: 34511970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Proteomics Unveil Novel Immune Signatures and Biomarkers upon SARS-CoV-2 Infection.
    Urbiola-Salvador V; Lima de Souza S; Grešner P; Qureshi T; Chen Z
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection.
    Captur G; Moon JC; Topriceanu CC; Joy G; Swadling L; Hallqvist J; Doykov I; Patel N; Spiewak J; Baldwin T; Hamblin M; Menacho K; Fontana M; Treibel TA; Manisty C; O'Brien B; Gibbons JM; Pade C; Brooks T; Altmann DM; Boyton RJ; McKnight Á; Maini MK; Noursadeghi M; Mills K; Heywood WE;
    EBioMedicine; 2022 Nov; 85():104293. PubMed ID: 36182629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.
    Ahsan N; Rao RSP; Wilson RS; Punyamurtula U; Salvato F; Petersen M; Ahmed MK; Abid MR; Verburgt JC; Kihara D; Yang Z; Fornelli L; Foster SB; Ramratnam B
    Proteomics; 2021 May; 21(10):e2000279. PubMed ID: 33860983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics-based mass spectrometry profiling of SARS-CoV-2 infection from human nasopharyngeal samples.
    Chatterjee S; Zaia J
    Mass Spectrom Rev; 2024; 43(1):193-229. PubMed ID: 36177493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive acute and sustained changes to neutrophil proteomes post-SARS-CoV-2 infection.
    Long MB; Howden AJM; Keir HR; Rollings CM; Giam YH; Pembridge T; Delgado L; Abo-Leyah H; Lloyd AF; Sollberger G; Hull R; Gilmour A; Hughes C; New BJM; Cassidy D; Shoemark A; Richardson H; Lamond AI; Cantrell DA; Chalmers JD; Brenes AJ
    Eur Respir J; 2024 Mar; 63(3):. PubMed ID: 38097207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-analysis of SARS-CoV-2-infected host cell proteomics time-course data by impact pathway analysis and network analysis: a potential link with inflammatory response.
    Bock JO; Ortea I
    Aging (Albany NY); 2020 Jun; 12(12):11277-11286. PubMed ID: 32575076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients.
    Park J; Kim H; Kim SY; Kim Y; Lee JS; Dan K; Seong MW; Han D
    Sci Rep; 2020 Dec; 10(1):22418. PubMed ID: 33376242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study.
    Hu Z; van der Ploeg K; Chakraborty S; Arunachalam PS; Mori DAM; Jacobson KB; Bonilla H; Parsonnet J; Andrews JR; Holubar M; Subramanian A; Khosla C; Maldonado Y; Hedlin H; de la Parte L; Press K; Ty M; Tan GS; Blish C; Takahashi S; Rodriguez-Barraquer I; Greenhouse B; Butte AJ; Singh U; Pulendran B; Wang TT; Jagannathan P
    Elife; 2022 Oct; 11():. PubMed ID: 36239699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
    Vishnubalaji R; Shaath H; Alajez NM
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.
    Meyers JM; Ramanathan M; Shanderson RL; Beck A; Donohue L; Ferguson I; Guo MG; Rao DS; Miao W; Reynolds D; Yang X; Zhao Y; Yang YY; Blish C; Wang Y; Khavari PA
    PLoS Pathog; 2021 Oct; 17(10):e1009412. PubMed ID: 34597346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients.
    Tornesello AL; Botti C; Micillo A; Labonia F; Arpino S; Isgrò MA; Meola S; Russo L; Cavalcanti E; Sale S; Nicastro C; Atripaldi L; Starita N; Cerasuolo A; Reimer U; Holenya P; Buonaguro L; Buonaguro FM; Tornesello ML
    J Transl Med; 2023 Feb; 21(1):123. PubMed ID: 36788606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system.
    Ayass MA; Cao W; Zhang J; Dai J; Zhu K; Tripathi T; Griko N; Pashkov V; Abi-Mosleh L
    PLoS One; 2022; 17(9):e0274228. PubMed ID: 36094909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual COVID-19 disease trajectories revealed by plasma proteomics.
    Memon D; Barrio-Hernandez I; Beltrao P
    EMBO Mol Med; 2021 Aug; 13(8):e14532. PubMed ID: 34260159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.